Variants of Insulin-signaling Inhibitor Genes in Type 2 Diabetes and Related Metabolic Abnormalities

Overview

Journal Int J Genomics

Publisher Wiley

Date 2013 Jun 14

PMID 23762820

Citations 8

Authors

Carlo De Lorenzo

Annalisa Greco

Teresa Vanessa Fiorentino

Gaia Chiara Mannino

Marta Letizia Hribal

Affiliations

Soon will be listed here.

Abstract

Insulin resistance has a central role in the pathogenesis of several metabolic diseases, including type 2 diabetes, obesity, glucose intolerance, metabolic syndrome, atherosclerosis, and cardiovascular diseases. Insulin resistance and related traits are likely to be caused by abnormalities in the genes encoding for proteins involved in the composite network of insulin-signaling; in this review we have focused our attention on genetic variants of insulin-signaling inhibitor molecules. These proteins interfere with different steps in insulin-signaling: ENPP1/PC-1 and the phosphatases PTP1B and PTPRF/LAR inhibit the insulin receptor activation; INPPL1/SHIP-2 hydrolyzes PI3-kinase products, hampering the phosphoinositide-mediated downstream signaling; and TRIB3 binds the serine-threonine kinase Akt, reducing its phosphorylation levels. While several variants have been described over the years for all these genes, solid evidence of an association with type 2 diabetes and related diseases seems to exist only for rs1044498 of the ENPP1 gene and for rs2295490 of the TRIB3 gene. However, overall the data recapitulated in this Review article may supply useful elements to interpret the results of novel, more technically advanced genetic studies; indeed it is becoming increasingly evident that genetic information on metabolic diseases should be interpreted taking into account the complex biological pathways underlying their pathogenesis.

Citing Articles

Retinoic acid and RARγ maintain satellite cell quiescence through regulation of translation initiation.

Luo W, Xu Y, Liu R, Liao Y, Wang S, Zhang H Cell Death Dis. 2022; 13(9):838.

PMID: 36175396 PMC: 9522790. DOI: 10.1038/s41419-022-05284-9.

69C>T Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Systematic Review and Updated Meta-Analysis.

Yoon H, Lee M, Song Y, Yee J, Song G, Gwak H Front Endocrinol (Lausanne). 2021; 12:639524.

PMID: 33967955 PMC: 8104122. DOI: 10.3389/fendo.2021.639524.

A new human adipocyte model with PTEN haploinsufficiency.

Kassner F, Kirstein A, Handel N, Schmid G, Landgraf K, Berthold A Adipocyte. 2020; 9(1):290-301.

PMID: 32579864 PMC: 7469440. DOI: 10.1080/21623945.2020.1785083.

Genome-Wide Association Study Reveals Multiple Novel QTL Associated with Low Oxygen Tolerance in Hybrid Catfish.

Zhong X, Wang X, Zhou T, Jin Y, Tan S, Jiang C Mar Biotechnol (NY). 2017; 19(4):379-390.

PMID: 28601969 DOI: 10.1007/s10126-017-9757-5.

Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.

Rizvi S, Raza S, Rahman Q, Mahdi F 3 Biotech. 2017; 6(2):255.

PMID: 28330327 PMC: 5135703. DOI: 10.1007/s13205-016-0572-x.

References

Cheyssac C, Lecoeur C, Dechaume A, Bibi A, Charpentier G, Balkau B . Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Med Genet. 2006; 7:44. PMC: 1525165. DOI: 10.1186/1471-2350-7-44. View

Gonzalez-Sanchez J, Martinez-Larrad M, Fernandez-Perez C, Kubaszek A, Laakso M, Serrano-Rios M . K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population. Obes Res. 2003; 11(5):603-5. DOI: 10.1038/oby.2003.86. View

Dahlman I, Wahrenberg H, Persson L, Arner P . No association of reported functional protein tyrosine phosphatase 1B 3' UTR gene polymorphism with features of the metabolic syndrome in a Swedish population. J Intern Med. 2004; 255(6):694-5. DOI: 10.1111/j.1365-2796.2004.01341.x. View

Seely B, Staubs P, Reichart D, Berhanu P, Milarski K, Saltiel A . Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes. 1996; 45(10):1379-85. DOI: 10.2337/diab.45.10.1379. View

Bacci S, Paola R, Menzaghi C, Di Fulvio P, Di Silvestre S, Pellegrini F . ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009; 29(10):1678-83. DOI: 10.1161/ATVBAHA.109.189191. View

Mo J, Wu J, Sun Z, Yang H, Lei M, Liu W . Association of PTP1B gene polymorphism with obesity in Chinese children. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010; 35(9):915-20. DOI: 10.3969/j.issn.1672-7347.2010.09.003. View

Liew C, Bochenski J, Kawamori D, Hu J, Leech C, Wanic K . The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J Clin Invest. 2010; 120(8):2876-88. PMC: 2912176. DOI: 10.1172/JCI36849. View

Meshkani R, Taghikhani M, Mosapour A, Larijani B, Khatami S, Khoshbin E . 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population. Arch Med Res. 2007; 38(5):556-62. DOI: 10.1016/j.arcmed.2007.01.010. View

Hamaguchi K, Terao H, Kusuda Y, Yamashita T, Hazoury Bahles J, Cruz LL M . The PC-1 Q121 allele is exceptionally prevalent in the Dominican Republic and is associated with type 2 diabetes. J Clin Endocrinol Metab. 2004; 89(3):1359-64. DOI: 10.1210/jc.2003-031387. View

10.

Lebovitz H . Insulin resistance--a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab. 2006; 8(3):237-49. DOI: 10.1111/j.1463-1326.2005.00521.x. View

11.

Kipfer-Coudreau S, Eberle D, Sahbatou M, Bonhomme A, Guy-Grand B, Froguel P . Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia. 2004; 47(7):1278-1284. DOI: 10.1007/s00125-004-1432-5. View

12.

Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy S, Sandeep S . ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes. 2005; 54(4):1207-13. DOI: 10.2337/diabetes.54.4.1207. View

13.

Palmer N, Bento J, Mychaleckyj J, Langefeld C, Campbell J, Norris J . Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes. 2004; 53(11):3013-9. DOI: 10.2337/diabetes.53.11.3013. View

14.

Morini E, Prudente S, Succurro E, Chandalia M, Zhang Y, Mammarella S . IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants. Diabetologia. 2009; 52(9):1852-7. PMC: 2782547. DOI: 10.1007/s00125-009-1426-4. View

15.

Kubaszek A, Markkanen A, Eriksson J, Forsen T, Osmond C, Barker D . The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth. J Clin Endocrinol Metab. 2004; 89(5):2044-7. DOI: 10.1210/jc.2003-031350. View

16.

Baratta R, Di Paola R, Spampinato D, Fini G, Marucci A, Coco A . Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms. J Mol Med (Berl). 2003; 81(11):718-23. DOI: 10.1007/s00109-003-0466-3. View

17.

Gu P, Jiang W, Du H, Shao J, Lu B, Wang J . Protein tyrosine phosphatase 1B gene polymorphisms and essential hypertension: a case-control study in Chinese population. J Endocrinol Invest. 2010; 33(7):483-8. DOI: 10.1007/BF03346629. View

18.

Panhuysen C, Cupples L, Wilson P, Herbert A, Myers R, Meigs J . A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study. Diabetologia. 2003; 46(4):579-87. DOI: 10.1007/s00125-003-1066-z. View

19.

Florez J, Agapakis C, Burtt N, Sun M, Almgren P, Rastam L . Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes. 2005; 54(6):1884-91. DOI: 10.2337/diabetes.54.6.1884. View

20.

Matsushima R, Harada N, Webster N, Tsutsumi Y, Nakaya Y . Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity. J Biol Chem. 2006; 281(40):29719-29. DOI: 10.1074/jbc.M511636200. View